Patent details

EP2624813 Title: COMPOSITION FOR INTRAOCULAR IMPLANTATION OF BEVACIZUMAB

Basic Information

Publication number:
EP2624813
PCT Application Number:
GB2011001458
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117733063
PCT Publication Number:
WO2012046009
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITION FOR INTRAOCULAR IMPLANTATION OF BEVACIZUMAB
French Title of Invention:
COMPOSITION POUR L'IMPLANTATION INTRAOCULAIRE DE BÉVACIZUMAB
German Title of Invention:
ZUSAMMENSETZUNG FÜR INTRAOKULARE IMPLANTATION VON BEVACIZUMAB
SPC Number:

Dates

Filing date:
07/10/2011
Grant date:
09/08/2017
EP Publication Date:
14/08/2013
PCT Publication Date:
12/04/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/08/2017
EP B1 Publication Date:
09/08/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/10/2017
Expiration date:
07/10/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/08/2017
 
 

Name:
UCL Business Plc.
Address:
The Network Building 97 Tottenham Court Road, London W1T 4TP, United Kingdom (GB)

Inventor

1

Name:
KHAW, Peng T.
Address:
United Kingdom (GB)

2

Name:
KHALILI, Ashkan
Address:
Iran (Islamic Republic) (IR)

3

Name:
BROCCHINI, Stephen
Address:
United Kingdom (GB)

Priority

Priority Number:
201017048
Priority Date:
08/10/2010
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 9/00; A61K 9/20; A61K 39/395;

Publication

European Patent Bulletin

Issue number:
201732
Publication date:
09/08/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2018 Outgoing Correspondence 1